Mesoblast Limited: REMESTEMCEL-L IMPROVES SURVIVAL OF CHILDREN WITH BIOMARKERS FOR HIGHEST MORTALITY IN STEROID REFRACTORY ACUTE GVHD

Press/Media

Period20 Oct 2021

Media coverage

1

Media coverage

  • TitleMesoblast Limited: REMESTEMCEL-L IMPROVES SURVIVAL OF CHILDREN WITH BIOMARKERS FOR HIGHEST MORTALITY IN STEROID REFRACTORY ACUTE GVHD
    Media name/outletImpact Financial News
    Country/TerritoryUnited Kingdom
    Date20/10/21
    Persons James Ferrara
View all 1
View less